H
VIRX
HoyleCohen’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $7.61K | Hold |
14,000
| – | – | ﹤0.01% | 274 |
|
|
2024
Q1 | $14.3K | Hold |
14,000
| – | – | ﹤0.01% | 281 |
|
|
2023
Q4 | $7.98K | Hold |
14,000
| – | – | ﹤0.01% | 270 |
|
|
2023
Q3 | $14.6K | Hold |
14,000
| – | – | ﹤0.01% | 259 |
|
|
2023
Q2 | $19.7K | Hold |
14,000
| – | – | ﹤0.01% | 260 |
|
|
2023
Q1 | $22.3K | Hold |
14,000
| – | – | ﹤0.01% | 258 |
|
|
2022
Q4 | $20.4K | Hold |
14,000
| – | – | ﹤0.01% | 263 |
|
|
2022
Q3 | $60K | Hold |
14,000
| – | – | 0.01% | 252 |
|
|
2022
Q2 | $54K | Hold |
14,000
| – | – | 0.01% | 254 |
|
|
2022
Q1 | $67K | Hold |
14,000
| – | – | 0.01% | 269 |
|
|
2021
Q4 | $51K | Hold |
14,000
| – | – | ﹤0.01% | 272 |
|
|
2021
Q3 | $112K | Hold |
14,000
| – | – | 0.01% | 263 |
|
|
2021
Q2 | $159 | Hold |
14,000
| – | – | 0.01% | 262 |
|
|
2021
Q1 | $130K | Buy |
+14,000
| New | +$130K | 0.01% | 261 |
|